These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11851742)

  • 1. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications.
    Autti-Rämö I; Larsen A; Taimo A; von Wendt L
    Eur J Neurol; 2001 Nov; 8 Suppl 5():136-44. PubMed ID: 11851742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: child characteristics that predict a positive outcome.
    Fehlings D; Rang M; Glazier J; Steele C
    Eur J Neurol; 2001 Nov; 8 Suppl 5():145-9. PubMed ID: 11851743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial.
    Love SC; Valentine JP; Blair EM; Price CJ; Cole JH; Chauvel PJ
    Eur J Neurol; 2001 Nov; 8 Suppl 5():50-8. PubMed ID: 11851734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.
    Rousseaux M; Kozlowski O; Froger J
    J Neurol; 2002 Jan; 249(1):76-84. PubMed ID: 11954872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures.
    Desloovere K; Molenaers G; Jonkers I; De Cat J; De Borre L; Nijs J; Eyssen M; Pauwels P; De Cock P
    Eur J Neurol; 2001 Nov; 8 Suppl 5():75-87. PubMed ID: 11851736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
    Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
    Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
    Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
    Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of three-dimensional kinematic analysis following upper limb botulinum toxin A for children with hemiplegia.
    Mackey AH; Miller F; Walt SE; Waugh MC; Stott NS
    Eur J Neurol; 2008 Nov; 15(11):1191-8. PubMed ID: 18727674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004; (3):CD003469. PubMed ID: 15266487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinematic aiming task: measuring functional changes in hand and arm movements after botulinum toxin-A injections in children with spastic hemiplegia.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Am J Phys Med Rehabil; 2007 Jul; 86(7):538-47. PubMed ID: 17581288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of addition of botulinum toxin-A to standardized therapy for dynamic manual skills measured with kinematic aiming tasks in children with spastic hemiplegia.
    Rameckers EA; Duysens J; Speth LA; Vles HJ; Smits-Engelsman BC
    J Rehabil Med; 2010 Apr; 42(4):332-8. PubMed ID: 20461335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R; Büyükavcı MA
    Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review.
    Park ES; Rha DW
    Yonsei Med J; 2006 Oct; 47(5):589-603. PubMed ID: 17066503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
    Saita K; Morishita T; Hyakutake K; Fukuda H; Shiota E; Sankai Y; Inoue T
    J Neurol Sci; 2017 Feb; 373():182-187. PubMed ID: 28131185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
    Carraro E; Trevisi E; Martinuzzi A
    Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.